UCB SA

PNK: UCBJF · Real-Time Price · USD
150.70
0.00 (0.00%)
At close: May 02, 2025, 8:00 PM
0.00%
Bid 150.7
Market Cap 28.64B
Revenue (ttm) 5.45B
Net Income (ttm) 240M
EPS (ttm) 6.21
PE Ratio (ttm) 24.27
Forward PE n/a
Analyst n/a
Ask 150.7
Volume 100
Avg. Volume (20D) 350
Open 150.70
Previous Close 150.70
Day's Range 150.70 - 150.70
52-Week Range 131.15 - 209.66
Beta 0.33

About UCBJF

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkin...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 26, 2008
Employees 9,052
Stock Exchange PNK
Ticker Symbol UCBJF
Full Company Profile